Economists have raised Singapore's economic growth forecast this year to 3.3 percent from an earlier 2.5 percent forecast in September.
Singtel, DBS and City Developments are among 237 international firms that have joined global initiative for companies to disclose climate change exposure and pave way for low-carbon economy.
Noble Group is talking to creditors about a conventional restructuring that includes a debt-for-equity swap, Bloomberg reported on Tuesday.
Brewing group Thai Beverage on Wednesday confirmed unit's interest in owning 25 percent or more of Sabeco, but it is yet to submit a formal bid for the Vietnam's biggest brewer.
Indian stocks fell on Tuesday as investors looked forward to macroeconomic data due later in the day amid a mixed trend in Asia.
Singapore shares extended gains to a third session on Tuesday, led by buying in lenders such as DBS Group and United Overseas Bank.
Singapore is the 21st most expensive city worldwide for expatriates, according to the latest cost of living survey by ECA International published on Tuesday.
Brewing group Thai Beverage emerged as the sole bidder willing to spend more than $2 billion for a stake in Saigon Beer Alcohol Beverage Corp.
Indian stocks fell on Tuesday as investors looked forward to macroeconomic data due later in the day amid a mixed trend in Asia.
Singapore shares snapped two-day rally on Tuesday, as investors booked profits in recent outperformers following sharp gains in the previous two sessions.
Dairy products sold by Lactalis in Singapore are not affected by the global recall of French company's formula milk products, the Agri-Food and Veterinary Authority (AVA) said.
Shares in Infinio Group jumped as much as 50 percent to S$0.003 on the Singapore Exchange on Tuesday.
Singapore-based medtech company Advent Access has raised S$2.6 million from Temasek to advance the development and commercialisation of its patented av-Guardian technology.
Brewing group Thai Beverage on Tuesday requested for a trading halt on its shares pending the release of an announcement.
Clearbridge Health plans to raise about S$24.6 million through its initial public offering on the Singapore Exchange (SGX) Catalist Board to build a healthcare business focused on precision medicine services.